SNGX - 1.57 NIH selects Soligenix's SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program https://stockcharts.com/c-sc/sc?s=SNGX&p=D&b=5&g=0&i=t71048186757&r=1536846667884